K
Karim Khader
Researcher at University of Utah
Publications - 56
Citations - 1476
Karim Khader is an academic researcher from University of Utah. The author has contributed to research in topics: Retrospective cohort study & Veterans Affairs. The author has an hindex of 15, co-authored 48 publications receiving 1162 citations. Previous affiliations of Karim Khader include United States Department of Veterans Affairs & Veterans Health Administration.
Papers
More filters
Journal Article
Vital Signs: Improving Antibiotic Use Among Hospitalized Patients
Scott K. Fridkin,James Baggs,Ryan Fagan,Shelley S. Magill,Lori A. Pollack,Paul Malpiedi,Rachel B. Slayton,Karim Khader,Michael Rubin,Makoto Jones,Matthew H. Samore,Ghinwa Dumyati,Elizabeth Dodds-Ashley,James Meek,Kimberly Yousey-Hindes,John A. Jernigan,Nadine Shehab,Rosa Herrera,L. Clifford McDonald,Amy Schneider,Arjun Srinivasan +20 more
TL;DR: There is ample opportunity to improve use and patient safety by reducing incorrect antibiotic prescribing and reducing potential harm and risk for antibiotic resistance by implementing formal programs to improve antibiotic prescribing in hospitals.
Journal ArticleDOI
Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.
Rachel B. Slayton,Damon J.A. Toth,Bruce Y. Lee,Windy Tanner,Sarah M. Bartsch,Karim Khader,Kim F. Wong,Kevin A. Brown,James A. McKinnell,William J. Ray,Loren G. Miller,Michael Rubin,Diane S. Kim,Frederick R. Adler,Chenghua Cao,Lacey Avery,Nathan T.B. Stone,Alexander J. Kallen,Matthew H. Samore,Susan S. Huang,Scott K. Fridkin,John A. Jernigan +21 more
TL;DR: Immediate nationwide infection control and antibiotic stewardship interventions, over 5 years, could avert an estimated 619,000 HAIs resulting from CRE, multidrug-resistant Pseudomonas aeruginosa, invasive methicillin-resistant Staphylococcus aureus (MRSA), or C. difficile.
Journal ArticleDOI
Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection.
Vanessa Stevens,Richard E. Nelson,Elyse M. Schwab-Daugherty,Karim Khader,Makoto Jones,Kevin A. Brown,Tom Greene,Lindsay D. Croft,Melinda M. Neuhauser,Peter A. Glassman,Matthew Bidwell Goetz,Matthew H. Samore,Michael Rubin +12 more
TL;DR: This retrospective, propensity-matched cohort study evaluated patients treated for CDI, defined as a positive laboratory test result for the presence of C difficile toxins or toxin genes in a stool sample, in the US Department of Veterans Affairs health care system from January 1, 2005, through December 31, 2012 to evaluate the risk of recurrence and all-cause 30-day mortality.
Journal ArticleDOI
Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review
Jennifer S. McDanel,Marin L. Schweizer,Victoria Crabb,Richard E. Nelson,Matthew H. Samore,Karim Khader,Amy E. Blevins,Daniel J. Diekema,Hsiu-Yin Chiang,Rajeshwari Nair,Eli N. Perencevich +10 more
TL;DR: The incidence of extended-spectrum β-lactamase (ESBL) Escherichia coli and Klebsiella infections in the United States has increased and incidence rates increased over time from 1997 to 2011, with slightly higher rates of ESBL-Klebsiello infections.
Journal ArticleDOI
Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis.
Hsiu-Yin Chiang,Eli N. Perencevich,Rajeshwari Nair,Richard E. Nelson,Matthew H Samore,Karim Khader,Margaret L. Chorazy,Loreen A. Herwaldt,Amy E. Blevins,Melissa A. Ward,Marin L. Schweizer +10 more
TL;DR: In this paper, a systematic review of the incidence of vancomycin-resistant enterococci (VRE) infection in the United States and the clinical and economic outcomes is presented.